Oscar Health Upgraded to Zacks Rank #1 Strong Buy on Surging Estimates

Zacks Investment Research··US·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Oscar Health, Inc. has been upgraded to a Zacks Rank #1 (Strong Buy), a rating reserved for the top 5% of the more than 4,000 stocks covered by the Zacks system. The upgrade reflects a sharp upward trend in earnings estimates, with the Zacks Consensus Estimate for the company climbing 290.1% over the past three months. Oscar Health is expected to earn $1.83 per share for the fiscal year ending December 2026, which represents no year-over-year change. The Zacks Rank is determined solely by a company's changing earnings picture, and Zacks Rank #1 stocks have generated an average annual return of +25% since 1988. The upgrade implies that the stock could move higher in the near term as institutional investors adjust valuations to the improved earnings outlook.

Impact on assets 2

Financials▲ · 1 stocks
Oscar Health Inc
OSCR
▲ PositiveCapitalrelevance

Oscar Health upgraded to Zacks Rank #1 Strong Buy on a 290.1% surge in earnings estimates over three months.

Aging Population▲ · 1 stocks